Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Platinum Compounds × Clear all

NCT06986057 2025-05-22

Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms